Shares of Avacta Group Plc (LON:AVCT – Get Free Report) fell 6.5% during mid-day trading on Thursday . The stock traded as low as GBX 42.27 ($0.53) and last traded at GBX 43.25 ($0.55). 1,947,396 shares traded hands during trading, a decline of 16% from the average session volume of 2,306,089 shares. The stock had previously closed at GBX 46.25 ($0.58).
Avacta Group Stock Performance
The firm has a market cap of £154.07 million, a PE ratio of -477.78 and a beta of 1.12. The stock has a 50-day moving average price of GBX 51.25 and a 200 day moving average price of GBX 57.55. The company has a debt-to-equity ratio of 63.54, a current ratio of 1.29 and a quick ratio of 4.96.
About Avacta Group
Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms.
Read More
- Five stocks we like better than Avacta Group
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- What is the Nasdaq? Complete Overview with History
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Best Aerospace Stocks Investing
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.